Stryker's LFIT V40 Femoral Head in 2026: the 42,000-Unit Recall, Taper-Lock Failure, and What to Check Before Time Runs Out
If you received a Stryker LFIT V40 femoral head, the short answer is that a 2016 recall flagged taper-lock failures in more than 42,000 units, a 2018 settlement resolved certain revision-surgery cases, and whether you can still file in 2026 depends on your implant, your revision history, and your state's deadline — not on the recall alone.
- August 29, 2016: Stryker recalled more than 42,000 LFIT V40 femoral head components after a higher-than-expected rate of taper-lock failures.
- November 2, 2018: a settlement was announced covering certain cases in a Massachusetts federal multidistrict litigation (about 125 cases) and a New Jersey state court (more than 140 cases).
- September 27, 2016: Australia's Therapeutic Goods Administration issued a hazard alert for seven LFIT V40 head sizes, 36 to 44 millimetres.
- The 2018 settlement terms were confidential, and the settlement did not cover every LFIT V40 claim.
You can also find plain-language explainers on the Problem Solved channel.
What the LFIT V40 Is — and What Went Wrong
The femoral head is the ball-shaped top of the thigh bone that fits into the hip socket. Stryker's LFIT Anatomic Cobalt Chromium V40 femoral head was paired with stems made from a different alloy, including the Accolade TMZF stem, and was meant to give smooth hip movement with a lower risk of dislocation. A taper lock is the friction fit that joins the femoral head to the neck of the hip stem. In the recalled units, that fit failed more often than expected: the head could wear against the stem, shed tiny metal particles, and loosen. Metallosis is tissue damage and inflammation caused by metal debris shed inside the body. Once metal debris spreads into surrounding tissue and the bloodstream, patients can face pain, inflammation, tissue death, and bone damage — and often a second operation.
The 2016 Recall in Plain Terms
On August 29, 2016, Stryker recalled more than 42,000 LFIT V40 metal femoral head components, telling surgeons the devices showed a higher-than-expected revision rate because of taper-lock failures. Revision surgery is an operation that removes a failed implant and replaces it with a new one. The hazards Stryker listed for the recalled heads included dissociation of the femoral head from the stem, stem fracture, implant dislocation, decreased range of motion, loss of implant and bone fixation, metallosis, damage to bone and tissue around the implant, periprosthetic fracture, inflammation, pain from loosening, joint instability, and leg length discrepancy. A month later, on September 27, 2016, Australia's Therapeutic Goods Administration issued a hazard alert for seven LFIT V40 head sizes, from 36 to 44 millimetres, citing the same higher-than-expected taper-lock failure rate. The recall did not mean every LFIT V40 head failed — it meant the failure rate was high enough that surgeons and patients needed to know.
The 2018 Settlement: What It Covered — and What It Did Not
On November 2, 2018, judges in Massachusetts federal court and New Jersey state court announced a settlement between Stryker and national plaintiffs' leadership counsel. The settlement covered certain cases involving LFIT V40 femoral heads used with certain stems, including Accolade TMZF, Accolade 2, Citation, Meridian, and Rejuvenate stems — and it covered certain non-recalled heads as well as recalled ones. Compensation varies widely by case, and most settlements are confidential: the LFIT V40 settlement terms were not publicly disclosed, and the amount in any individual case depended on case-specific factors such as the degree of harm and the extent of permanent injury. Critically, the settlement did not cover all filed claims. Patients whose cases fell outside its terms, and patients who had not yet filed, were left with the ordinary route: an individual claim governed by their state's law and deadlines.
How LFIT V40 Differs From Stryker's Other Hip Settlements
Stryker has faced more than one hip-implant crisis, and mixing them up is the most common source of confusion. The widely reported Stryker hip settlement covered the Rejuvenate and ABG II stems — different components with their own corrosion problem — while the LFIT V40 matter concerns the femoral head that sits on top of a stem. A patient can therefore hold a recalled LFIT V40 head without holding a recalled stem, and vice versa. If you are checking your own history, the component name on your surgical record matters more than the brand name on the box. Related Stryker coverage on this site includes the Stryker hip settlement and the DePuy hip implant litigation, which involve different devices and different settlements.
Signs That Point to an LFIT V40 Problem
No symptom proves a device failed — only records and testing can do that — but the hazards in the recall notice give patients a concrete checklist to discuss with their surgeon. Watch for new or worsening hip pain, a feeling that the hip is loosening or unstable, dislocation, a change in leg length, reduced range of motion, or swelling and inflammation around the joint. Surgeons investigating a suspected LFIT V40 failure typically check blood metal-ion levels, imaging, and the implant record itself. If you still have the device, ask your surgeon's office for the implant sticker or operative report: it names the exact component, and that name decides whether the LFIT V40 recall and settlement touch your case at all.
Who Benefits From This — and Who Does Not
This article is most useful for people in four situations. First, patients who received an LFIT V40 femoral head and later needed revision surgery: you are the group the 2018 settlement was built around, and your surgical records are the key evidence. Second, patients who still carry an LFIT V40 head and have new hip symptoms: the recall hazard list gives you specific questions to take to your surgeon before a small problem becomes a revision. Third, family members helping an older relative who had hip surgery years ago and no longer remembers the device name: the implant record can be retrieved from the hospital, and that single document answers the threshold question. Fourth, patients weighing whether a new claim is even possible: the sections below give you the dates and distinctions that decide that question. This article is not for everyone. It does not help patients whose hip used a different Stryker component, such as a Rejuvenate or ABG II stem without an LFIT V40 head — those cases fall under the separate stem settlement, covered in our Stryker hip settlement guide. It also does not help patients whose symptoms have no link to the implant: ordinary age-related hip pain, without a recalled component or a documented failure, is not an LFIT V40 claim. And it is not a substitute for medical advice: any decision about monitoring, testing, or revision surgery belongs to you and your surgeon.
What to Check Before Time Runs Out
Start with the implant record. Contact the hospital or surgeon that performed your hip replacement and request the operative report and implant sticker; confirm whether the words LFIT V40 appear. Next, gather your revision history: dates of any second operation, the reason recorded for it, and any blood metal-ion test results. Then check your state's deadline. Statutes of limitations for device claims vary by state, and the clock can run from the implant date, the revision date, or the date you discovered the problem, depending on state law — so a claim that looks old may still be open, and a claim that looks fresh may already be late. Do not wait for a letter from a manufacturer or a law firm: the recall happened in 2016, and delay is the one mistake that cannot be undone. Keep every document in one folder, including the recall notice if you received one, and get any legal review in writing so you know exactly what was filed and when.
This article is general information, not legal or medical advice. Device claims turn on individual facts and state law; consult a qualified attorney and your surgeon about your own situation.
Frequently Asked Questions
Who benefits most from understanding the LFIT V40 recall?
Patients who received an LFIT V40 femoral head and later needed revision surgery benefit most, because the 2018 settlement was built around revision cases — and patients who still carry the device benefit from knowing the warning signs early.
Who does not benefit, or is not eligible?
Patients whose hip used a different component, such as a Rejuvenate or ABG II stem without an LFIT V40 head, fall under a separate settlement, and patients whose hip pain has no documented link to a recalled component do not have an LFIT V40 claim.
How do I start checking whether I have a claim?
Request your operative report and implant sticker from the hospital or surgeon, confirm whether LFIT V40 appears, gather your revision history and any metal-ion test results, then get a legal review before your state's deadline passes.
What exactly was recalled in 2016?
More than 42,000 LFIT Anatomic Cobalt Chromium V40 femoral head components were recalled on August 29, 2016, because of a higher-than-expected rate of taper-lock failures.
Does the 2018 settlement block a new claim?
Not necessarily. The settlement covered certain cases only, its terms were confidential, and it did not cover every LFIT V40 claim — whether a new claim is still possible depends on your implant, your history, and your state's deadline.
How is compensation decided in these cases?
Compensation varies widely by case, and most settlements are confidential. In LFIT V40 cases the amount has depended on case-specific factors such as the degree of harm and the extent of permanent injury, not on a fixed schedule.